ahk cu reconstitution AHK-Cu · Disguised Alpha AHK-CU - Receptor Chem

Full evaluation of an AHK-Cu protocol requires at least six months, preferably a year

In that sense, if 5-amino-1MQ had effects on the same molecular pathways as exercise, aged mice treated with the compound that also exercised would not receive much of an effect from the treatment

Results vary and are not guaranteed

Are B12 Injections Right for Everyone

At the molecular level, 5-amino-1MQ functions as a competitive inhibitor of NNMT, demonstrating remarkable potency with an IC of 1.2 0.1 M under standard assay conditions (50 M SAM, 100 M nicotinic acid). This represents a dramatic 10-fold improvement over the parent compound 1-methylquinolinium, achieved through strategic amino group substitution that enhances binding affinity to the NNMT active site. The compound's mechanism centers on preventing the methylation of nicotinamide to 1-methylnicotinamide (1-MNA), thereby preserving nicotinamide for recycling back to NAD+ through the salvage pathway. This intervention effectively blocks what researchers have termed the "NNMT metabolic drain" a process that simultaneously depletes NAD+ precursors and consumes cellular methylation capacity